Rein Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-94.3M | $3.8M |
| FY2016 | — | $-111.8M | $20.7M |
| FY2017 | — | $47.8M | $11.9M |
| FY2018 | — | $19.6M | $10.6M |
| FY2019 | — | $16.0M | $5.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $-94.3M | $3.8M |
| FY2016 | — | $-111.8M | $20.7M |
| FY2017 | — | $47.8M | $11.9M |
| FY2018 | — | $19.6M | $10.6M |
| FY2019 | — | $16.0M | $5.3M |